Below are a list of revision made to the Bioterrorism Handbook
by date.
October 2003
The following Centers for Disease Control and
Prevention (CDC) link provides an Evaluation Tool of a
Rash Illness Suspicious of Smallpox.
This evaluation tool includes six questions and
criteria information for Clinicians. Caution: Use this
tool only when there is no release or circulation of
smallpox.
http://www.bt.cdc.gov/agent/smallpox/diagnosis/riskalgorithm/index.asp
January 2003
Section V - Update Information
- Notice to Readers: Use of Anthrax Vaccine in
Response to Terrorism: Supplemental Recommendations of
the Advisory Committee on Immunization Practices (ACIP),
p. 33
- Overview: In December 2000, the ACIP
released its recommendations for using anthrax
vaccine in the U.S. Because of recent terrorist
attacks involving the intentional exposure of U.S.
civilians to Bacillus anthracis spores and
concerns that the current anthrax vaccine supply is
limited, ACIP developed supplemental recommendations
on using anthrax vaccine in response to terrorism.
These recommendations supplement the previous ACIP
statement in three areas: use of anthrax vaccine for
pre-exposure vaccination in the U.S. civilian
population, the prevention of anthrax by post
exposure prophylaxis (PEP), and recommendations for
additional research related to using antimicrobial
agents and anthrax vaccine for preventing anthrax.
- Reference additions: Bozzette, S., et al. A Model
for a Smallpox Vaccination Policy, N Engl J Med 2003:
348;5, Smallpox websites, pp. 94
Section VI.- Addendum
Kansas Department of Health and Environment (KDHE)-
Guidelines for Management of a Suspect Case of Smallpox
in Acute Care Medical Settings in Kansas, pp. 90
Adobe Acrobat Reader Required
©, Copyright, 2004 Sedgwick County Health Department
last update:
06/24/04
Please report problems to the webmaster
ALL RIGHTS RESERVED
Your
Government
